Pneumococcal Bacteremia Presenting as Acute Parotitis and Sepsis by Ashish Kataria, Alan S. Multz

“…The underlying imunosupression caused by SLE and long-term steroid treatment could have predisposed this patient to invasive Pneumococcal disease.…”
Get full text

Pneumococcal Tricuspid Valve Endocarditis in a Young African American: A Case for Inclusion of African Americans in Pneumococcal Vaccine Criteria by Oghenerukevwe Odiete, Olagoke Akinwande, John J. Murray, Joseph Akamah

“…However, certain independent risk factors such as cigarette smoking and being of African-American (AA) decent have been associated with a higher incidence of invasive pneumococcal disease, but only cigarette smoking has been targeted by current recommendations from the Advisory Committee on Immunological Practices (ACIPs). …”
Get full text

Hemolytic Uremic Syndrome Associated with Pneumococcal Pneumonia. A Case Report by Ariel Efrén Uriarte Méndez, Andrés Prieto Apesteguía, Jesús Vila Díaz, Jorge Luis Capote Padrón, Kendrie Villavicencio Cardoso, Alnilam Fernández González

“…When there is an invasive pneumococcal disease as underlying condition, it has a mortality rate of 25%, and half of the surviving cases develop end-stage renal disease (ESRD). …”
Get full text

Serotypes and antimicrobial resistance of Streptococcus pneumoniae in Chinese pediatric population: a scoping review by Xu Han, Haiyang Yu, Niurka Molina Águila, María Eugenia Toledo Romaní

“…Long-term, high-quality surveillance of the serotype distribution and antimicrobial resistance of Streptococcus pneumoniae is necessary for the development of pneumococcal disease prevention.…”
Get full text

Nasopharyngeal carriage of Streptococcus pneumoniae in Latin America and the Caribbean: A systematic review and meta-analysis. by Martín Brizuela, María Carolina Palermo, Tomás Alconada, María Macarena Sandoval, Eugenia Ramirez Wierzbicki, Joaquín Cantos, Paula Gagetti, Agustín Ciapponi, Ariel Bardach, Silvina Ruvinsky

“…<h4>Background</h4>Streptococcus pneumoniae is a leading cause of morbidity and mortality globally, causing bacteremic pneumonia, meningitis, sepsis, and other invasive pneumococcal diseases. Evidence supports nasopharyngeal pneumococcal carriage as a reservoir for transmission and precursor of pneumococcal disease.…”
Get full text

Impact of COVID-19 on testing, positive cases, patient characteristics, and hospital contacts for respiratory syncytial virus, influenza, and pneumococcus in Danish children by Andreas Jensen, Lone Graff Stensballe

“…This comprehensive study investigates the impact of these interventions on the incidence of respiratory syncytial virus, influenza, and invasive pneumococcal disease in Danish children. Methods: We conducted a descriptive study based on a cohort of 1,790,464 Danish children from 2012 to 2022. …”
Get full text

Genomic Analysis of a Serotype 5 Streptococcus pneumoniae Outbreak in British Columbia, Canada, 2005–2009 by Ruth R. Miller, Morgan G. I. Langille, Vincent Montoya, Anamaria Crisan, Aleksandra Stefanovic, Irene Martin, Linda Hoang, David M. Patrick, Marc Romney, Gregory Tyrrell, Steven J. M. Jones, Fiona S. L. Brinkman, Patrick Tang

“…Streptococcus pneumoniae can cause a wide spectrum of disease, including invasive pneumococcal disease (IPD). From 2005 to 2009 an outbreak of IPD occurred in Western Canada, caused by a S. pneumoniae strain with multilocus sequence type (MLST) 289 and serotype 5. …”
Get full text

Closer adult child–parent relations the stronger the vaccine hesitancy: A cross-sectional study of adult Children’s attitudes toward pneumococcal vaccination of elderly parents and... by Qiqi Wu, Haiyuan Zhu, Runquan Zhang, Cuizhi Li, Qin Xiao, Yuqing Jin, Xiaofeng Liang, Xiongfei Chen, Xiaomei Dong

“…Pneumococcal disease (PD) has a serious effect on older people aged 60 years and above. …”
Get full text

Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trial. by Anna Roca, Philip C Hill, John Townend, Uzo Egere, Martin Antonio, Abdoulie Bojang, Abiodun Akisanya, Teresa Litchfield, David E Nsekpong, Claire Oluwalana, Stephen R C Howie, Brian Greenwood, Richard A Adegbola

“…<h4>Background</h4>Introduction of pneumococcal conjugate vaccines (PCVs) of limited valency is justified in Africa by the high burden of pneumococcal disease. Long-term beneficial effects of PCVs may be countered by serotype replacement. …”
Get full text

Immunisation schedule of the Pediatric Spanish Association: 2024 recommendations by Francisco José Álvarez García, Antonio Iofrío de Arce, Javier Álvarez Aldeán, Elisa Garrote Llanos, Lucía López Granados, María Luisa Navarro Gómez, Valentín Pineda Solas, Irene Rivero Calle, Jesús Ruiz-Contreras, Ignacio Salamanca de la Cueva, Pepe Serrano Marchuet, Francisco José Álvarez García, Antonio Iofrío de Arce, Javier Álvarez Aldeán, María Garcés-Sánchez, Elisa Garrote Llanos, Abián Montesdeoca Melián, María Luisa Navarro Gómez, Valentín Pineda Solas, Irene Rivero Calle, Jesús Ruiz-Contreras, Pepe Serrano Marchuet

“…The AEP 2025 Vaccination and Immunization Schedule recommended for children, adolescents and pregnant women residing in Spain features the following novelties:Due to the increase in measles cases and outbreaks in recent years, we recommend advancing the second dose of measles, mumps and rubella (MMR) vaccine to 2 years of age.As a consequence of the above, since many autonomous communities (ACs) use the quadrivalent vaccine for the second dose of MMR and varicella vaccines, we recommend, for all ACs, advancing the second dose of varicella vaccine to 2 years of age.Due to the very significant increase in cases of pertussis since late 2023 and especially in 2024, we recommend advancing the dose of Tdap given in adolescence to 10–12 years of age.To complete protection against meningococcal disease in adolescence, we recommend vaccination against MenB at age 12 years.We believe that vaccination against seasonal influenza should be routine up to age 18 years, but given the disappointing coverage in children aged 6–59 months, we currently consider that improving this coverage should be prioritised, extending vaccination to children and adolescents aged 5–18 years once this objective has been achieved.Among other aspects, the routine immunization tables for healthy individuals and risk groups, the use of the new extended-valence conjugate vaccines against pneumococcal disease, routine vaccination at 4 months of age with MenACWY and vaccination against SARS-CoV-2 for individuals aged more than 6 months with risk factors remain unchanged with respect to the 2024 schedule. …”
Get full text

Impacts of the 13-Valent Pneumococcal Conjugate Vaccine in Children by Susanna Esposito, Nicola Principi

“…We reviewed the effects of PCV13 in the control of pneumococcal diseases in children based on previous studies.…”
Get full text

Vaccinations for Hajj: Enhancing health and global health security by Anas A. Khan, Bander S. Balkhi, Fahad A. Alamri, Ghadah S. Alsaleh, Jaffar A. Al-Tawfiq, Hani Jokhdar

“…Mandatory vaccination protocols against Meningococcal Meningitis, Yellow Fever, Influenza, pneumococcal diseases, and COVID-19 have demonstrated significant success in controlling infection spread during Hajj. …”
Get full text

Effect of Hemoadsorption for Cytokine Removal in Pneumococcal and Meningococcal Sepsis by Francesca Leonardis, Viviana De Angelis, Francesca Frisardi, Chiara Pietrafitta, Ivano Riva, Tino Martino Valetti, Valentina Broletti, Gianmariano Marchesi, Lorenza Menato, Roberto Nani, Franco Marson, Mirca Fabbris, Luca Cabrini, Sergio Colombo, Alberto Zangrillo, Carlo Coniglio, Giovanni Gordini, Lucia Stalteri, Giovanni Giuliani, Vittorio Dalmastri, Gaetano La Manna

“…From this first experience, extracorporeal cytokine removal seems to be a valid and safe therapy in the management of meningococcal and pneumococcal diseases and may contribute to the patient stabilization and prevention of severe sequelae. …”
Get full text

Nasopharyngeal carriage of Streptococcus pneumoniae among Brazilian children: Interplay with viral co-infection. by Kauana Pizzutti, Juliana Comerlato, Daniele Vargas de Oliveira, Amanda Robaina, Mariana Preussler Mott, Pedro Uriel Pedrotti Vieira, Tiago Fetzner, Gabriela Rosa da Cunha, Muriel Primon de Barros, Jaqueline Verardo, Neide Maria Bruscato, João Carlos Batista Santana, Roberta Rigo Dalla Corte, Emilio Hideyuki Moriguchi, Vlademir Vicente Cantarelli, Cícero Armídio Gomes Dias

“…Nasopharyngeal transmission of Streptococcus pneumoniae is a prerequisite for the development of pneumococcal diseases. Previous studies have reported a relationship between respiratory viruses and S. pneumoniae infections. …”
Get full text